Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Epstein

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Cancer Genetics and Cytogenetics|June 20, 2002
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogeneHiroshi Moritake, Tohru Sugimoto, Yujiro Asada, et al.
Biochemical and Biophysical Research Communications|October 15, 2022
Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppressionJessica A Lapierre, Lauren A Geary, Julie K Jang, et al.
Journal of Immunology Research|September 1, 2016
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsAlison Smith, Hugh Manoli, Stacey Jaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2020
A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma ModelsLong Zheng, Luqing Ren, Aida Kouhi, et al.
Journal of Translational Medicine|June 11, 2011
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesMelissa G Lechner, Carolina Megiel, Sarah M Russell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2022
Restoration of Follicular T Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j MicePrabhakaran Kumar, Sivasangari Balakrishnan, Swarali Surendra Lele, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2014
BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltrationTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Journal of Immunological Methods|January 3, 2013
Generation of tumor-targeted antibody-CpG conjugatesZhongjun Li, Julie K Jang, Melissa G Lechner, et al.
BMC Cancer|November 16, 2019
Expression of the luteinizing hormone receptor (LHR) in ovarian cancerShigang Xiong, Paulette Mhawech-Fauceglia, Denice Tsao-Wei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2019
OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB SignalingPrabhakaran Kumar, Swarali Surendra Lele, Vandhana K Ragothaman, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Cancer Genetics and Cytogenetics|June 20, 2002
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogeneHiroshi Moritake, Tohru Sugimoto, Yujiro Asada, et al.
Biochemical and Biophysical Research Communications|October 15, 2022
Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppressionJessica A Lapierre, Lauren A Geary, Julie K Jang, et al.
Journal of Immunology Research|September 1, 2016
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsAlison Smith, Hugh Manoli, Stacey Jaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2020
A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma ModelsLong Zheng, Luqing Ren, Aida Kouhi, et al.
Journal of Translational Medicine|June 11, 2011
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesMelissa G Lechner, Carolina Megiel, Sarah M Russell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2022
Restoration of Follicular T Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j MicePrabhakaran Kumar, Sivasangari Balakrishnan, Swarali Surendra Lele, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2014
BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltrationTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Journal of Immunological Methods|January 3, 2013
Generation of tumor-targeted antibody-CpG conjugatesZhongjun Li, Julie K Jang, Melissa G Lechner, et al.
BMC Cancer|November 16, 2019
Expression of the luteinizing hormone receptor (LHR) in ovarian cancerShigang Xiong, Paulette Mhawech-Fauceglia, Denice Tsao-Wei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2019
OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB SignalingPrabhakaran Kumar, Swarali Surendra Lele, Vandhana K Ragothaman, et al.
Pageof 10